Get up-to-date product and event news, including information on our generic products.
Medroxyprogesterone Acetate Injectable Suspension, USP, (pre-filled syringe) distributed by Greenstone LLC may contain two different product expiration dates printed on its individual components. Please note that the date printed on the outer carton of the combination pack should be considered as the overall expiration date of the combination product.
There are no known safety or labeling concerns which have been associated with this situation.
Read more »PEAPACK, NJ, June 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Dofetilide Capsules to its ever-expanding generic pharmaceutical product line. The product is offered and available in dosage strengths of 125 mcg (0.125 mg) x 60 capsules per bottle, 250 mcg (0.250 mg) x 60 capsules per bottle and 500 mcg (0.5 mg) x 60 capsules per bottle.
Read more »PEAPACK, NJ, January 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of tolterodine tartrate extended release capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 2 mg x 30 capsules per bottle, 2 mg x 90 capsules per bottle, 4 mg x 30 capsules per bottle, and 4 mg x 90 capsules per bottle.
Read more »PEAPACK, NJ, January 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Colestipol Hydrochloride Granules for Oral Suspension to its ever-expanding generic pharmaceutical product line. The product is offered and available in cartons of 30 foils of 5 grams each, cartons of 90 foils of 5 grams each, and bottles of 500 grams with scoop.
Read more »PEAPACK, NJ, December 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of linezolid tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 600 mg x 20 tablets per bottle and 600 mg x unit dose packages of 20 tablets.
Read more »PEAPACK, NJ, November 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of linezolid for oral suspension to its ever-expanding generic pharmaceutical product line. The product is offered in powder form in dosage strengths of 100 mg / 5 mL x 150 mL as reconstituted suspension.
Read more »PEAPACK, NJ, October 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of ethosuximide capsules and ethosuximide oral solution to its ever-expanding generic pharmaceutical product line. The capsules are offered in dosage strength of 250 mg in bottles of 100 counts, and the oral solution in a dosage strength of 250 mg/5 mL as oral solution.
Read more »PEAPACK, N.J., February, 2015 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Trandolapril/Verapamil Hydrochloride Extended Release (ER) tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 1mg/240mg x 100; 2mg/180mg x100; 2mg/240mg x 100; 4mg/240mg x 100.
Read more »PEAPACK, N.J., December 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of CELECOXIB to its ever-expanding generic pharmaceutical product line. The product is offered in capsule form in dosage strengths of 50 mg x 60 capsules per bottle; 100 mg x 100 capsules per bottle; 100 mg x 500 capsules per bottle; 200 mg x 100 capsules per bottle; 200 mg x 500 capsules per bottle; and 400 mg x 60 capsules per bottle.
Read more »PEAPACK, N.J., November 2014 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), announced, on October 27, 2014, the introduction of sirolimus tablets to its ever-expanding generic pharmaceutical product line. The product is offered as 1 mg and 2 mg tablets in bottles of 100 tablets each.
Read more »PEAPACK, NJ, September 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of cabergoline tablets to its ever-expanding generic pharmaceutical product line. The product is offered in tablet form in dosage strengths of 0.5 mg x eight tablets per bottle.
Read more »PEAPACK, NJ, July 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of Doxazosin Mesylate tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 1 mg x 100; 2 mg x 100; 4 mg x 100 and 8 mg x 100.
Read more »PEAPACK, N.J., May 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Nadolol tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 20 mg x 100; 40 mg x 100 and 80 mg x 100.
Read more »PEAPACK, N.J., April 2014 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Rifabutin Capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strength of 150mg x 100.
Read more »PEAPACK, N.J., March 2014 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Piroxicam Capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 10mg x 100 and 20mg x 100.
Read more »PEAPACK, N.J., January, 2014 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Tolterodine Tartrate Tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 1mg x 60; 1mg x500; 2mg x 60 and 2mg x500.
Read more »Pfizer initiates voluntary recall of two lots of Pfizer's EFFEXOR XR® 150 mg extended-release capsules and one lot of Greenstone's VENLAFAXINE HCL 150 mg extended-release capsules. Click here for more information.
Read more »Call the Pharmacy Locator Service at 1-855-222-8588 to find your GREENSTONE medicine at a pharmacy near you.
